172 related articles for article (PubMed ID: 24981059)
21. IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent.
Stremska ME; Dai C; Venkatadri R; Wang H; Sabapathy V; Kumar G; Jose S; Mohammad S; Sung SJ; Fu SM; Sharma R
J Autoimmun; 2019 Aug; 102():133-141. PubMed ID: 31103267
[TBL] [Abstract][Full Text] [Related]
22. Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice.
Fairhurst AM; Mathian A; Connolly JE; Wang A; Gray HF; George TA; Boudreaux CD; Zhou XJ; Li QZ; Koutouzov S; Banchereau J; Wakeland EK
Eur J Immunol; 2008 Jul; 38(7):1948-60. PubMed ID: 18506882
[TBL] [Abstract][Full Text] [Related]
23. TLR4
Ma K; Li J; Wang X; Lin X; Du W; Yang X; Mou F; Fang Y; Zhao Y; Hong X; Chan KW; Zhang X; Liu D; Sun L; Lu L
Ann Rheum Dis; 2018 Oct; 77(10):1498-1506. PubMed ID: 29925508
[TBL] [Abstract][Full Text] [Related]
24. Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis.
Bagavant H; Tung KS
J Immunol; 2005 Jul; 175(2):944-50. PubMed ID: 16002693
[TBL] [Abstract][Full Text] [Related]
25. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
Davison LM; Jørgensen TN
Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
[TBL] [Abstract][Full Text] [Related]
26. B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.
Jacob N; Guo S; Mathian A; Koss MN; Gindea S; Putterman C; Jacob CO; Stohl W
J Immunol; 2011 Apr; 186(8):4984-93. PubMed ID: 21383240
[TBL] [Abstract][Full Text] [Related]
27. Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.
Mathian A; Mouries-Martin S; Dorgham K; Devilliers H; Barnabei L; Ben Salah E; Cohen-Aubart F; Garrido Castillo L; Haroche J; Hie M; Pineton de Chambrun M; Miyara M; Sterlin D; Pha M; Lê Thi Huong D; Rieux-Laucat F; Rozenberg F; Gorochov G; Amoura Z
Arthritis Rheumatol; 2019 May; 71(5):756-765. PubMed ID: 30507062
[TBL] [Abstract][Full Text] [Related]
28. Neutrophils, Dendritic Cells, Toll-Like Receptors, and Interferon-α in Lupus Nephritis.
Lorenz G; Anders HJ
Semin Nephrol; 2015 Sep; 35(5):410-26. PubMed ID: 26573544
[TBL] [Abstract][Full Text] [Related]
29. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis.
Waters ST; McDuffie M; Bagavant H; Deshmukh US; Gaskin F; Jiang C; Tung KS; Fu SM
J Exp Med; 2004 Jan; 199(2):255-64. PubMed ID: 14718514
[TBL] [Abstract][Full Text] [Related]
30. Immune cells and type 1 IFN in urine of SLE patients correlate with immunopathology in the kidney.
Scott E; Dooley MA; Vilen BJ; Clarke SH
Clin Immunol; 2016 Jul; 168():16-24. PubMed ID: 27102764
[TBL] [Abstract][Full Text] [Related]
31. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
[TBL] [Abstract][Full Text] [Related]
32. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
33. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
34. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
[TBL] [Abstract][Full Text] [Related]
35. Deficiency of the type I interferon receptor protects mice from experimental lupus.
Nacionales DC; Kelly-Scumpia KM; Lee PY; Weinstein JS; Lyons R; Sobel E; Satoh M; Reeves WH
Arthritis Rheum; 2007 Nov; 56(11):3770-83. PubMed ID: 17968932
[TBL] [Abstract][Full Text] [Related]
36. Ultraviolet light induces increased T cell activation in lupus-prone mice via type I IFN-dependent inhibition of T regulatory cells.
Wolf SJ; Estadt SN; Theros J; Moore T; Ellis J; Liu J; Reed TJ; Jacob CO; Gudjonsson JE; Kahlenberg JM
J Autoimmun; 2019 Sep; 103():102291. PubMed ID: 31248690
[TBL] [Abstract][Full Text] [Related]
37. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
Hua J; Kirou K; Lee C; Crow MK
Arthritis Rheum; 2006 Jun; 54(6):1906-16. PubMed ID: 16736505
[TBL] [Abstract][Full Text] [Related]
38. Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.
Corradetti C; Jog NR; Cesaroni M; Madaio M; Caricchio R
J Immunol; 2018 Jan; 200(2):512-522. PubMed ID: 29237779
[TBL] [Abstract][Full Text] [Related]
39. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.
Koh AE; Njoroge SW; Feliu M; Cook A; Selig MK; Latchman YE; Sharpe AH; Colvin RB; Paul E
J Autoimmun; 2011 Aug; 37(1):48-57. PubMed ID: 21561736
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.
Lauwerys BR; Hachulla E; Spertini F; Lazaro E; Jorgensen C; Mariette X; Haelterman E; Grouard-Vogel G; Fanget B; Dhellin O; Vandepapelière P; Houssiau FA
Arthritis Rheum; 2013 Feb; 65(2):447-56. PubMed ID: 23203821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
